HOXA11 and central nervous system cancer: To validate these findings, we performed real-time quantitative PCR (RT-qPCR) analysis of RNA expression in 41 glioma samples and found much higher levels of HOXA11-AS in WHO III-IV grade than that in WHO II grade (Fig. 1C).